4th Circ. Questions Basis For Generic-Drug Injury Appeal
Fourth Circuit judges on Thursday repeatedly interrupted an attorney's argument that failure-to-warn claims against Pliva Inc. aren't preempted by a landmark U.S. Supreme Court generic-drug liability ruling, questioning whether his client...To view the full article, register now.
Already a subscriber? Click here to view full article